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Introduction: The effectiveness of pandemic vaccine campaigns such as the H1N1 vaccine 
rollout is dependent on both the vaccines’ effectiveness and the general public’s willingness 
to be vaccinated. It is therefore critical to understand the factors that influence the decision of 
members of the public whether to get vaccinated with new, emergently released vaccines.
Methods: A systematic review of English language quantitative surveys was conducted to 
identify consistent predictors of the decision to accept or decline any (pre)pandemic vaccine, 
including the H1N1 influenza A vaccine. A total of ten studies were included in this review 
and all pertained to the 2009 H1N1 influenza A pandemic. Respondents’ willingness to receive 
a pandemic vaccine ranged from 8%–67% across the ten studies. The factors reported to be 
consistent predictors of the intention to vaccinate were: risk of infection, proximity or severity 
of the public health event, severity of personal consequences resulting from the illness, harm 
or adverse events from the vaccine, acceptance of previous vaccination, and ethnicity. Age and 
sex were the demographic variables examined most frequently across the ten studies and there 
was no consistent association between these variables and the intention to accept or reject a 
pandemic vaccine.
Conclusion: Some predictors of the intention to accept or decline a (pre)pandemic vaccine or 
the H1N1 influenza A vaccine are consistently identified by surveys. Understanding the important 
factors influencing the acceptance of a pandemic vaccine by individual members of the public 
may help inform strategies to improve vaccine uptake during future pandemics.
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Introduction
The release of a pandemic vaccine to protect individuals from H1N1 was an unprecedented 
undertaking for many nations across the world. The development-to-  implementation 
process of a new, emergency-released vaccine like the H1N1 vaccine differs in 
many ways from that of established vaccines, such as the seasonal influenza vaccine. 
Given the urgent need for a vaccine during the H1N1 pandemic or similar emergency 
situations, a vaccine must be developed and distributed in an efficient and timely 
manner to reduce the overall public health burden of the disease. Furthermore, a 
large portion of the population must be vaccinated within a short period to maximize 
the benefits of the vaccine. Vaccination campaigns that are successful in encourag-
ing the general public to get vaccinated can help reduce the morbidity and mortality 
related to the emerging disease. Understanding the factors that influence decisions 
made by individual members of the public to accept or decline an emergency-released 
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vaccine such as the H1N1 vaccine can help public health 
officials in preparedness planning and management activities 
for future infectious disease outbreaks.
Several surveys have examined the factors that influ-
enced the uptake of the H1N1 vaccine. A systematic review 
of the published survey literature was conducted to synthe-
size the data from these studies and identify barriers and 
facilitators to vaccination that were consistently identified 
across studies.
Methods
Search strategy
A systematic search of the literature for all articles was 
conducted on July 26, 2010 using the MEDLINE (Ovid 
interface: January 1950 to July 26, 2010), EMBASE 
(Ovid interface: 1947 to July 26, 2010), and PsycINFO 
(Ovid interface: 1806 to July 26, 2010) databases. The search 
strategy for the MEDLINE database was based on medi-
cal subject headings and keywords. The research librarian 
ensured that the coding was as inclusive and exhaustive as 
possible and provided guidance in transporting the search 
strategy into other databases. The search strategy combined 
terms that represented attitudes, perceptions, and barriers 
and facilitators with “H1N1 influenza” and “pandemic 
vaccine.” The searches were supplemented by a review of 
the references of key articles on the topic. The full search 
strategies are presented in the Appendix.
Study selection
All abstracts generated by the searches were added to a 
database and duplicates were removed prior to screening. 
Two reviewers independently screened the abstracts for 
eligibility. Agreement between reviewers on the selection 
of studies was compared using a Kappa score. All English 
articles that met the following criteria were included in 
the final meta-synthesis: sampled the general public and 
not a specific population; examined H1N1 pandemic, or 
swine flu, or other prepandemic vaccines and vaccination/
immunization; examined personal intention or willingness 
to get vaccinated, or actual vaccination rate, or barriers 
and/or predictors of intention to personally receive or 
having received the vaccination; obtained data through a 
quantitative survey.
Any disagreement between the reviewers was discussed 
and resolved by consensus. In cases where consensus was 
not achieved, a third reviewer addressed any discrepancies 
that arose.
Data abstraction
Two reviewers independently extracted data from the eligible 
studies and a third addressed any discrepancies that arose. 
From a preliminary review of the articles, the two reviewers 
developed a coding template, using the constant comparative 
method.1 The factors influencing vaccine use identified in 
the studies were categorized using this coding template, 
which consisted of broad headings termed “themes,” and 
subheadings termed “categories.”2 The reviewers conducted 
a second review of the articles to extract quantitative survey 
data pertaining to the themes in the coding template. The 
quantitative data extracted from the studies had to meet one 
of the following criteria of significance; either: odds ratio 
(OR) values with a P-value of ,0.05, or when a P-value is 
not provided the 95% confidence interval must not include 
the value of 1, or the factors were indicated by the author(s) 
of the study to be statistically significant. If both univariate 
and multivariate analyses were available, data from the 
multivariate analyses were preferentially extracted. When 
the data were presented as percentage values, the top three 
responses for a given question were reported. The authors 
of all the studies included in the analysis were emailed and 
requested to review the information that was extracted to help 
ensure that the data extracted represented the data and results 
presented in the authors’ respective publications.
Statistical analysis
Kappa scores were calculated to determine chance-adjusted 
interobserver agreement in the abstract and study selection 
processes. Due to the heterogeneity of the populations and 
survey methods covered by the studies included in the review, 
as well as a lack of guidelines on combining survey data, a 
meta-analysis was not conducted.
Results
Study selection and characteristics
The search strategy yielded 720 abstracts and titles (Figure 1). 
Of these, 51studies met selection criteria and the full articles 
were pulled for further analysis. A total of ten studies met the 
final inclusion criteria and were included in the systematic 
review. There was excellent agreement between the two 
reviewers for the initial screening of the abstracts (κ = 0.97) 
and the final articles (κ = 1.00).
The characteristics of the studies included in the 
review are summarized in Table 1. The studies included 
in the analysis surveyed the general population of adults 
aged $18 years, except for one study that surveyed   participants 
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aged $16 years.3 The methods of survey administration 
included telephone surveys (n = 4), online surveys (n = 3), 
paper-based surveys (n = 2), and one survey was conducted 
in person. Five of the surveys were self-administered.4–8 The 
sample size of the ten studies ranged from 2079 to 51753 
respondents. The response rate for the surveys ranged from 
8%3 to 80%.9 Three studies were conducted in the USA,4,5,9 
four were conducted in Europe,3,6,8,10 two studies took place 
in Australia,7,11 and one in Hong Kong.12 All of the studies 
took place during the H1N1 influenza A pandemic. Five of 
these surveys were administered before the availability of the 
H1N1 vaccine in the respective countries.3,5,7,9,12
Studies identified in initial search
n = 720
Duplicates excluded
n = 242
Studies remaining after
removing duplicates
n = 478
Studies added
from manual
search
n = 2
Relevant studies remaining
after screening
n = 51
Studies included in the
analysis after full-text review
n = 10
Studies excluded n = 429
Unrelated n = 253
Other infectious disease vaccines n = 79
Seasonal influenza vaccine n = 33
Emergency response willingness n = 16
Other preventative behaviours n = 15
Knowledge, attitudes, behavioral response
unrelated to vaccine n = 13
Community pandemic preparedness planning n = 9
Reviews n = 6
Focus groups/interviews n = 3
Antiviral drugs n = 2
Studies excluded n = 41
Other emergency released vaccines n = 22
Population refers to healthcare workers n = 7
Vaccine recommendation to others n = 5
Vaccine is not primary intervention n = 2
Outcomes do not include barriers or facilitators of
vaccine use n = 2
Focus group n = 1
Article language in Dutch n = 1
Does not report odds ratios or percentages n = 1
Medline n = 392
Embase n = 294
PsycINFO n = 34
Figure 1 Flow diagram of selection of studies for the systematic review.
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Intention to vaccinate
The reported willingness of the respondents to receive the 
pandemic vaccine was evaluated in nine studies and this 
ranged from 8%5 to 67%.11 A study conducted by Maurer 
and colleagues was   conducted after the vaccination cam-
paign and reported an actual   vaccination rate of 20% for 
H1N1 influenza A vaccine in their study population.4
Factors influencing intention to receive  
vaccination
Table 2 reports the factors identified in the studies that influ-
enced intention or willingness to receive a pandemic vaccine. 
The factors were categorized under the following themes: per-
sonal risk perception, vaccination attitude,   communications 
and information sources, access, demographic variables, and 
others. The major themes summarized factors that share simi-
larities and these themes are further divided into categories 
within each theme.
Personal risk perception
Nine studies were identified to report data under the 
theme personal risk perception.3,5–12 Of these, data 
on the perception of harm or adverse events from the 
vaccine were reported in seven studies.5–7,9–12 Two of the 
seven studies5,12 reported ORs of 0.11, 0.33, and 0.36, 
demonstrating that these concerns were associated with a 
lower intention to be vaccinated. Among the factors with 
the largest effect size for the intention to vaccinate was 
the perception of harm or adverse events from vaccine; 
in one study, participants who were more worried about 
the vaccine were 90% less likely to accept the vaccine 
(OR = 0.11).5 Five studies reported the perception of harm 
or adverse events from the vaccine as one of the top three 
factors influencing the decision to accept or decline the 
new vaccine.6,7,9–11 Four studies presented data on factors 
relating to the perception of the proximity or severity 
of the public health issues and reported ORs ranging 
from 1.2 to 2.5, suggesting that this factor increased the 
intention to vaccinate.3,6,7,11 Four studies presented data on 
the perception of the severity of personal consequences 
from the illness and reported ORs ranging from 1.64 
to 3.61.5,6,8,9 Five studies reported data pertaining to 
perceptions of the risk of infection with ORs ranging from 
1.55 to 4.7.3,7–10 In one study, participants who had higher 
levels of worry about personally catching the pandemic flu 
were almost five times more likely to accept the vaccine 
(OR = 4.7).3
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vaccination attitude
Seven studies were identified to report data under the theme of 
vaccination attitude.5–9,11,12 Two studies reported this theme as 
one of the top three factors influencing the   decision to accept or 
decline the new vaccine.7,11 Data   relating to people’s acceptance of 
previous vaccination on their intention to vaccinate was reported 
by seven studies5–9,11,12 and six of these studies reported ORs 
ranging from 1.27 to 5.03, suggesting that this factor increased the 
intention to vaccinate.5–7,9,11,12 Acceptance of previous vaccination 
was the factor with the largest effect on the intention to vaccinate, 
with those who accepted previous influenza vaccination shown 
to be five times more likely to accept a pandemic vaccine 
(OR = 5.03) in one study.11 Information on people’s belief of 
  vaccine effectiveness or necessity and antivaccination attitude 
were less consistently reported and only four studies reported 
data on these two categories.7,8,11,12
Communications and information sources
Seven studies were identified to report data under the theme 
of communications and information sources.3,4,6,8–10,12 Within 
this larger theme the following categories were identified: rec-
ommendations from healthcare professionals, public health 
messages, knowledge of the disease or vaccine, and influence 
of family and friends. These categories were less consistently 
reported, with less than three studies   reporting on each of 
the categories. Three of the seven studies reported nonsig-
nificant association between this theme and the intention to 
vaccinate.8–10 In one study, recommendations from health 
care professionals had a large effect on the intention to 
vaccinate based on the different levels of advice given by 
health care professionals. Respondents who received positive 
advice from a primary care physician for vaccination were 
more likely to accept the pandemic vaccine (OR = 4.57), and 
those who did not receive positive advice were more likely 
to decline the vaccine (OR = 0.57).6
Access
Four studies were identified to report data under the theme of 
access.5,6,8,9 Within this broad theme the following categories 
were identified: priority group, convenience, financial costs/
insurance, and vaccine delivery. Three of the four studies 
reported nonsignificant association between access and the 
intention to accept a pandemic vaccine.5,8,9 One study reported 
an odds ratio of 5.09 for acceptance of a pandemic vaccine for 
those in a priority group compared to those who were not.6
Demographic variables
The association between demographic variables and intention to 
accept or decline a pandemic vaccine are summarized in Table 3. 
Seven of ten studies reported data on the association between 
age and the intention to accept a pandemic vaccine.3,6,7,9–12 The 
association was not significant in three of the seven studies.7,9,12 
Furthermore, there was inconsistency about which age group 
is more likely to accept a pandemic vaccine for studies 
reporting significant associations. Eight studies reported on the 
association between sex and the intention to accept a pandemic 
vaccine, which was shown to be not significant in five3,7–9,12 of 
the eight studies.3,6–12 Four studies reported on the association 
Table 3 Demographic variables identified as predictors of vaccination with a pandemic vaccine by the general public
Quinn  
et al5
Sypsa  
et al10
Eastwood  
et al11
Horney  
et al9
Lau  
et al12
Maurer  
et al4
Rubin  
et al3
Schwarzinger  
et al6
Seale  
et al7
Zijtregtop 
et al8
Age 1.85a 1.64b NS NS 1.6b 1.41a NS
2.11a
Sex 2.75c 1.86d NS NS NS 0.57c NS NS
Ethnicity 3.27e NS 1.9e 1.6e
Education 0.40f NS 0.53g NS
Community/household-
related factors
1.60h
1.56i
NS
NS 2.1h
NS
1.68h
0.61i
NS
Personal health 0.41 1.5j
1.4j
NS
Occupation/social  
grade/work status
NS NS   NS 1.49–2.18k
Marital status NS
Notes: Real numbers represent odds ratios; bold indicates that the outcome is the intention to vaccinate, while normal type indicates that the outcome is the intention 
to not vaccinate; aolder age groups compared to younger age group (#34 years old); byounger age groups compared to older age group (60 + years old); creference is 
men; dreference is women; eother ethnic backgrounds compared to white/caucasian; fhigher levels of education compared to high school level of education; glower levels of 
education compared to university education; hphysical household related variable; iphysical community related variable; jdifferent statements about one’s health; kvariety of 
occupations compared to clerical.
Abbreviation: NS, no statistical significance in the association between the category with the intention to vaccinate or not vaccinate.
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between ethnicity and the intention to accept a pandemic 
vaccine.3,5,7,9 The reported ORs ranged from 1.6 to 3.27 for a 
higher intention to accept a pandemic vaccine in people who 
were not of Caucasian background, in countries composed of 
a heterogeneous mix of ethnic groups.3,5,7 Other demographic 
variables included education, community/household-related 
factors, personal health, occupation/social grade/work status, 
and marital status. For all of these, there was no clear trend 
toward statistical significance.
Discussion
In a public health emergency, promoting the uptake of an 
emergency-released vaccine by the target population can be 
a difficult challenge for public health authorities. If such a 
challenge is not properly addressed, it may impede efforts 
to manage the infectious disease. Determining the factors 
  influencing the intention to accept or decline a pandemic 
  vaccine may inform strategies to promote vaccination uptake 
in case of future public health emergencies. Specific strategies 
to address factors influencing the public’s reluctance to be 
vaccinated with a pandemic vaccine may increase the rate 
of overall vaccine uptake and help public health authorities 
better manage the emerging public health concern.
This study systematically reviewed the existing survey 
literature on factors influencing the intention to accept or 
decline a pandemic vaccine. The findings of a survey are 
generally limited to the population from which they were 
obtained. However, if multiple surveys in several   different 
geographical regions sampling different populations 
consistently identify similar findings, then the generalizability 
of the findings is increased.
Based on the findings of this review, issues relating to 
personal risk perceptions, including severity of the public 
health issue, risk of being infected by the virus, risk of severe 
illness from being infected, and risk of harm from a pandemic 
vaccine, are important factors that should be considered 
for future emergency vaccination campaigns. Developing 
strategies to modify people’s perception of their own risk 
may help encourage members of the general public to obtain 
vaccinations during public health emergencies. The findings 
also suggest that targeted messaging should perhaps be used 
for individuals of different ethnic groups in countries with 
a heterogeneous mix of ethnic groups, such as Canada and 
the USA, to reach groups that are more reluctant to accept a 
pandemic vaccine during a public health emergency.
Studies that did not meet the inclusion criteria but 
examined similar constructs, identified similar findings. 
A study conducted in 1976 by Cummings and colleagues13 
reported factors that played a significant role in explaining 
variance in the behavioral intention to vaccinate; these 
were: perceived susceptibility and perceived severity of the 
disease, perceived efficacy of vaccination, and physician’s 
recommendation. Together, these factors accounted for 37.8% 
of the variance in the behavioral intention to   vaccinate. Levine 
and colleagues14 also reported perceived risk as an indepen-
dent facilitator of the likelihood to vaccinate. While address-
ing a previous influenza pandemic threat, these findings are 
consistent with the observations of this review. The findings 
from this review are also consistent with studies using other 
research methodologies. Focus groups conducted by Henrich 
and colleagues15 reported perception of risk of infection, 
severity of morbidity from infection, proximity and ease of 
spread of the disease, and concerns about the safety of the 
new vaccine, as being among the factors influencing the deci-
sion to vaccinate with a novel vaccine during a pandemic. A 
meta-analysis of the relationship between risk perception and 
vaccination behavior found strong   evidence that perceived 
risk of getting the disease, perceived self-susceptibility to the 
disease, and perceived severity of consequences significantly 
predicted vaccination.16 In their review, Bish and collegues17 
also reported perceived susceptibility to the disease and per-
ceived severity of the disease as important predictors of pro-
tective behaviors, such as vaccination,   during a pandemic.
The present review has important limitations. The review 
is specific but not sensitive for identifying generalizable 
themes. If a theme is not reported to be a consistent predictor 
of vaccination intention it may be a consequence of surveys not 
asking a specific question related to the theme, or not reporting 
data related to the theme. It is also limited by the biases inherent 
in the original studies, including response bias and social 
desirability bias. The responses the individuals gave of their 
intention to get vaccinated may not be a true indication of how 
they would behave in an actual pandemic, as intention does not 
consistently translate to behavior. Further research exploring 
the factors that influenced the vaccination behavior during the 
H1N1 pandemic is necessary for a complete understanding 
of the behavior pre- and postpandemic. Further, the results 
presented are also not generalizable to non-English-speaking 
populations. Non-English-language papers were specifically 
excluded because translation could result in distortion of 
meaning of themes and subsequent misclassification. Another 
limitation resulting from the exclusion of non-English-
language papers is the possibility of reporting biases that may 
occur as statistically significant (positive) studies are more 
likely to be submitted and accepted for publication and are 
more likely to be published in English.18
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Conclusion
This review suggests that across different populations, the 
factors consistently associated with intention to accept or 
decline a pandemic vaccine include personal risk perception, 
vaccination attitude, and ethnicity. In future, emergency 
vaccination campaigns’ public health officials should be 
cognizant of these issues in hope of increasing acceptance 
of a pandemic vaccine by the general public. In particular, 
the components of personal risk perception and vaccination 
attitude represent potentially modifiable factors that officials 
could develop strategies to influence, prior to and during the 
release of an emergent vaccine. By addressing these factors 
proactively public health officials may increase the uptake 
of an emergently released vaccine and reduce the overall 
impact of the emerging disease.
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Appendix
Search strategies
Database: Ovid MEDLINE® in-process  
and other nonindexed citations  
and Ovid MEDLINE® 1950 to present
Search strategy
  1    Vaccination/or Mass Vaccination/or vaccin$.tw. (181200)
  2 Anthrax Vaccines/or Smallpox Vaccine/or Influenza 
Vaccines/or (H1N1 or swine flu or H5N1 or avian flu or 
bird flu).tw. (21236)
  3  1 or 2 (189137)
  4  Disease Outbreaks/or (pandemic$ or epidemic$ or out-
break$).tw. (113889)
  5  Bioterrorism/or emergencies/or (bioterror$ or emergency 
or emergent).tw. (146705)
  6  4 or 5 (257604)
  7  3 and 6 (17661)
  8 Attitude/or attitude$.tw. (98801)
  9  Perception/or (perception$ or perceive$).tw. (174307)
10  communication barriers/or barrier$.tw. (114683)
11    “Patient Acceptance of Health Care”/or (accept$ or 
  rejection or willingness).tw. (301968)
12    Motivation/or Intention/or (intention$ or motivat$).tw. 
(110507)
13    Health Knowledge, Attitudes, Practice/or “Attitude of 
Health Personnel”/(118620)
14    exp decision making/or (decision$ adj1 making).tw. 
(122071)
15  or/8–14 (890811)
16  7 and 15 (1182)
17  animals/not humans/(3425576)
18  16 not 17 (1100)
19  qualitative research/or qualitative.tw. (87357)
20    interview/or health surveys/or interviews as topic/or 
  narration/or questionnaires/or Focus Groups/(299201)
21    (interview$ or survey$ or focus group$ or questionnaire$ 
or narrat$ or experience$).tw. (1039040)
22    Observation/or observation$.tw. (469567)
23    or/19–22 (1613210)
24    18 and 23 (392)
25    from 24 keep 1–392 (392)
Database: EMBASE Classic plus  
EMBASE 1947 to 2010 July 22
Search strategy
1    vaccination/or mass immunization/or vaccin$.tw. (168265)
2    anthrax vaccine/or smallpox vaccine/or influenza vaccine/
or avian influenza vaccine/(19211)
  3    (H1N1 or swine flu or H5N1 or avian flu or bird flu).
tw. (6132)
  4  or/1–3 (176731)
  5    epidemic/or (pandemic$ or epidemic$ or outbreak$).
tw. (89724)
  6    biological warfare/or (bioterror$ or emergency or 
emergent).tw. (116221)
  7  5 or 6 (203711)
  8  4 and 7 (15798)
  9  health personnel attitude/or nurse attitude/or physician 
attitude/or patient attitude/(48932)
10  attitude/or attitude$.tw. (73587)
11  perception/or (perception$ or perceive$).tw. (142016)
12  barrier$.tw. (97777)
13  (accept$ or rejection or willingness).tw. (278073)
14  behavior/or motivation/(105523)
15  (intention$ or motivat$).tw. (71526)
16    decision making/or (decision$ adj1 making).tw. 
(78039)
17  or/9–16 (782106)
18    qualitative research/or qualitative.tw. (73896)
19    exp interview/(60764)
20    health survey/(75971)
21    exp questionnaire/(164048)
22    information processing/(66875)
23    (interview$ or survey$ or focus group$ or questionnaires$ 
or narrat$ or experience$).tw. (850724)
24    observational study/or observation$.tw. (489505)
25    or/18–24 (1509918)
26    8 and 17 and 25 (294)
27    from 26 keep 1–294 (294)
Database: PsycINFO® 1806 to  
July week 3 2010
Search strategy
1  immunization/or vaccin$.tw. (2506)
2    (h1n1 or swine flu or h5n1 or avian flu or bird flu).tw. 
(99)
3    1 or 2 (2583)
4    epidemics/or (pandemic$ or epidemic$ or outbreak$).
tw. (7129)
5    Bioterrorism/or (bioterror$ or emergency or emergent).
tw. (18614)
6  4 or 5 (25567)
7  3 and 6 (291)
8    Health Personnel Attitudes/or Health Attitudes/or 
  Attitudes/or attitude$.tw. (166439)
9  Communication Barriers/or barrier$.tw. (25197)
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10    Risk Perception/or Perception/or (perception$ or 
  perceive$).tw. (265390)
11    (accept$ or rejection or willingness).tw. (90606)
12    Consumer Behavior/or Client Attitudes/(23532)
13      Intention/or Motivation/or (intention$ or motivat$).tw. 
(123477)
14    decision making/or choice behavior/(41198)
15  (decision$ adj1 making).tw. (44649)
16  or/8–14 (610471)
17  Qualitative Research/or qualitative.tw. (56552)
18  interviews/(5241)
19    Mail Surveys/or Consumer Surveys/or Telephone 
  Surveys/or Surveys/(5346)
20    questionnaires/(11041)
21    (interview$ or survey$ or focus group$ or questionnaire$ 
or narrat$ or experience$).tw. (647996)
22    observation methods/or observation$.tw. (90753)
23    or/17–22 (731033)
24    7 and 16 and 23 (34)
25    from 24 keep 1–34 (34)
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